CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $343,000 | -38.6% | 5,468 | -25.9% | 0.02% | -47.1% |
| Q4 2021 | $559,000 | -39.5% | 7,380 | -10.6% | 0.03% | -34.6% |
| Q3 2021 | $924,000 | +4.6% | 8,254 | +43.1% | 0.05% | -18.8% |
| Q4 2020 | $883,000 | -50.8% | 5,770 | -73.1% | 0.06% | +10.3% |
| Q3 2020 | $1,796,000 | -53.6% | 21,472 | -59.2% | 0.06% | -42.0% |
| Q2 2020 | $3,870,000 | +9.9% | 52,662 | -36.5% | 0.10% | +7.5% |
| Q1 2020 | $3,520,000 | +10.1% | 82,992 | +58.0% | 0.09% | +106.7% |
| Q4 2019 | $3,198,000 | – | 52,515 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |